Lab Automation News and Research

RSS

QIAGEN to acquire Ipsogen

QIAGEN N.V. has made an offer and entered into exclusive negotiations to purchase a 47% initial stake in Ipsogen S.A. and subsequently make a public offer to fully acquire a global leader in molecular profiling and personalized healthcare diagnostics for a broad range of hematological cancers.

From QIAGEN Manchester Limited 15 Jun 2011

Visual Healthcare Lab Automation Platform gains traction with private industrial clients

Visual Healthcare Corp. announces that its new Lab Automation module is quickly gaining traction with private sector industrial clients.

8 Apr 2011

HighRes Biosolutions to build High-Throughput Laboratory Network for LANL-UCLA

A compact, self-contained, automated system for surveillance and screening of potential pandemic strains of influenza and other deadly infectious diseases is a step closer to reality, thanks to an agreement between Los Alamos National Laboratory, the University of California Los Angeles School of Public Health, and HighRes Biosolutions of Boston, Massachussets.

1 Feb 2011

Agilent opens new life sciences instruments manufacturing facility in Singapore

Agilent Technologies Inc. today announced the opening of its new life sciences instruments manufacturing facility in Singapore. The facility will produce the company's Liquid Chromatography/Mass Spectrometry (LC/MS) instruments for the global market.

30 Oct 2010

QIAGEN, Abbott enter agreement to strengthen testing menus for automated in-vitro diagnostic applications

QIAGEN and Abbott today announced that they have entered into an agreement that significantly strengthens both companies' testing menus for automated in-vitro diagnostic applications in the United States and Canada. Financial terms were not disclosed.

From QIAGEN Manchester Limited 13 Oct 2010

HighRes Biosolutions to install automation platform in China

HighRes Biosolutions, the leader in laboratory automation for life sciences, announced today that it is building a system for an undisclosed laboratory in Shanghai, China. The new system will be installed in the fall of 2010 by HighRes and Tekon Biotech Ltd, the Asian distributor representing HighRes in this region.

24 Aug 2010

HighRes Biosolutions, Tekon Biotech announce exclusive distribution agreement

HighRes Biosolutions, the leader in laboratory automation solutions for life science applications, announced today that it has selected Tekon Biotech Ltd., a leading full-service distributor to analytical and research laboratories, as exclusive distributor of its uniquely modular automation technologies to the top laboratories of China, Hong Kong and Taiwan.

22 Jul 2010

IRIS International, Amerinet announce new supply agreement

IRIS International, Inc. a leading manufacturer of urinalysis systems and consumables for use in hospitals and commercial laboratories worldwide, today announced a new supply agreement for its full product line of automated and semi-automated urinalysis systems, related products, consumables and services agreements, with Amerinet Inc., a leading national healthcare group purchasing organization servicing more than 41,000 provider facilities, including 2,537 acute care hospitals.

13 Jul 2010

HighRes Biosolutions to provide high-throughput screening automation to Rigel

HighRes Biosolutions, the leader in laboratory automation solutions for life science, announced today that it will be providing high-throughput screening automation to Rigel Pharmaceuticals, a South San Francisco, California-based clinical-stage drug development company.

13 Jul 2010

ZyGEM announces acquisition of MicroLab Diagnostics

ZyGEM Corp. Ltd., today announced that it has acquired MicroLab Diagnostics Inc., a private company developing microfluidic devices for rapid DNA testing. ZyGEM intends to market products integrating its unique DNA extraction and reagents and detection assays with the breakthrough microfluidic chip technology developed by MicroLab, which will operate as a business unit of the new company.

24 May 2010

FDA accepts for review Abbott's novel diagnostic test for rapid detection of NGAL

A novel diagnostic test to rapidly detect neutrophil gelatinase-associated lipocalin (NGAL), an early biomarker that identifies patients at risk for acute kidney injury (AKI), has been accepted for review by the United States Food and Drug Administration. If approved, this would be the first test available for use in the United States for the detection of NGAL.

1 Apr 2010

Study: Automatic reporting of estimated GFR may result in unnecessary referrals by physicians

With a concern that the automatic reporting of estimated glomerular filtration rate (the flow rate of filtered fluid through the kidney, which is used to define the stage and severity of chronic kidney disease) may result in unnecessary referrals by physicians, new research indicates that automated laboratory reporting was associated with a significant increase in first-time visits to a kidney specialist, particularly among those at increased risk of late detection of kidney disease (such as older or female patients), according to a study in the March 24/31 issue of JAMA.

27 Mar 2010

SBS, ALA merger awaits membership approval

For the past 18 months, the Society for Biomolecular Sciences and the Association for Laboratory Automation have been strategizing a merger to unite their complementary missions within the context of one inclusive organization -- the Society for Laboratory Automation and Screening. The SBS-ALA merger awaits membership approval via a proxy voting process.

16 Mar 2010

ZyGEM introduces new RNAGEM Tissue RNA extraction kits

ZyGEM Corp. Ltd., a provider of innovative enzyme-based products for DNA and RNA extraction and other life sciences applications, today announced the launch of its new RNAGEM™ Tissue RNA extraction kits. This product represents a significant advance in sample preparation for RNA-based testing and analysis.

2 Mar 2010

Arrayit achieves technological breakthrough in microarray production

Arrayit Corporation, a life sciences and healthcare technology leader, today announced that the Company has made a technological breakthrough in the speed and efficiency by which it manufactures its proprietary microarrays, which are tiny glass substrates that contain rows and columns of printed spots used for scientific research and molecular diagnostics.

22 Dec 2009

ZyGEM signs an agreement with VERITAS Japan to distribute DNA extraction products to the Japanese market

ZyGEM Corp. Ltd., a provider of innovative enzyme-based products for DNA extraction and other life sciences applications, today announced it has entered into an exclusive agreement with VERITAS Japan to distribute ZyGEM's DNA extraction products to the Japanese market.

29 Oct 2009